FormDSignal
65

Senti Biosciences, Inc. raises $37.6M under Reg D

Company raise · Raising · SOUTH SAN FRANCISCO, CA · Form D filed 2024-12-19
$50M+ raiseFirst raise on EDGARPlacement agent engaged

Why now — by persona

Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.

People on the filing

Brenda CooperstoneDirector
Kanya RajangamExecutive Officer
James CollinsDirector
Yvonne LiExecutive Officer
Donald TangDirector
Timothy LuExecutive Officer, Director
Edward MathersDirector
Fran SchulzDirector

Signed by Timothy Lu, M.D., Ph.D., Chief Executive Officer.

Placement agents / sales compensation: Leerink Partners LLC

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.

Other filings by this issuer